Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model

BACKGROUND: The aims of the present study were to determine the relationship between bone destruction and bone formation in the delayed-type hypersensitivity arthritis (DTHA) model and to evaluate the effect of receptor activator of nuclear factor κB ligand (RANKL) blockade on severity of arthritis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Atkinson, Sara Marie, Bleil, Janine, Maier, René, Kühl, Anja A., Thorn, Mette, Serikawa, Kyle, Fox, Brian, Kruse, Kim, Haase, Claus, Skov, Søren, Nansen, Anneline, Syrbe, Uta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724155/
https://www.ncbi.nlm.nih.gov/pubmed/26801240
http://dx.doi.org/10.1186/s13075-016-0931-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724155/
https://www.ncbi.nlm.nih.gov/pubmed/26801240
http://dx.doi.org/10.1186/s13075-016-0931-3

Ejemplares similares